Delivery Order SPE2DB25D3201-SPE2DB26FNNKT
Award Date 10/16/25
Potential Completion Date 10/17/25
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,429.76 for Cathflo Activase 2 mg vials on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The product will be delivered to...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of Cathflo Activase 2 mg vials, a thrombolytic medication used in medical settings. This firm fixed-price delivery order, valued at $5,429.76, is scheduled for completion by August 27, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $2,626.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for Cathflo Activase 2 mg vials, with an ultimate completion date of August 15, 2025. This non-set-aside competitive award was issued on August 14, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $2,714.88 to AmerisourceBergen Drug Corp for Cathflo Activase 2 mg vials, a thrombolytic medication used in medical settings. The order was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 11, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and a major...
- This delivery order, awarded on July 14, 2025, represents a $16,342.05 firm fixed-price purchase of Cathflo Activase 2 mg vials issued to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA). The award is not a set-aside contract and carries an ultimate completion date of July 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this order at its Corporate Office location. Cathflo Activase is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,232.63 to AmerisourceBergen Drug Corp for the supply of Cathflo Activase 2 mg vials, effective August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- This delivery order, valued at $4,524.80, was awarded to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Cathflo Activase 2 mg vials. The contract is a firm fixed price, non-set-aside award funded by the Defense Logistics Agency (DLA) and is scheduled for completion by July 21, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under the company's broader pharmaceutical...
- This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution company. The $6,783.73 firm fixed price delivery order is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product. The contract has a completion date of December 22, 2023. Amerisourcebergen Drug Corp has received numerous prior contract awards from DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, issued by the Defense Logistics Agency (DLA), is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a critical pharmaceutical product. The $2,570.16 firm fixed-price delivery order has a completion date of July 11, 2024. Amerisourcebergen, a major pharmaceutical distributor, is leveraging its extensive supply chain network to fulfill this contract. The company holds a larger Indefinite Delivery Contract (IDC)...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $9,934.48 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 2 mg vials of Cathflo Activase. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania with completion by December 5, 2023. No set-aside designation was applied to this award made against an indefinite delivery contract held by Amerisourcebergen Drug Corp with...